Ngā hua rapu - Hong-Bin Fang

Whakamahine hua
  1. 1
    Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection

    Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection mā Yun Su, Hong‐Bin Fang, Feng Jiang

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Small non-coding RNA biomarkers in sputum for lung cancer diagnosis

    Small non-coding RNA biomarkers in sputum for lung cancer diagnosis mā Yun Su, Maria Guarnera, Hong‐Bin Fang, Feng Jiang

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells

    Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells mā Elena A. Govorkova, Hong‐Bin Fang, Ming Tan, Robert G. Webster

    I whakaputaina 2004
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

    Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers mā Lingxiao Xing, Nevins W. Todd, Lei Yu, Hong‐Bin Fang, Feng Jiang

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer

    Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer mā Ning Li, Jie Ma, Maria Guarnera, Hong‐Bin Fang, Ling Cai, Feng Jiang

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer

    NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer mā Rong Hu, Anni Wärri, Lü Jin, Alan Zwart, Rebecca B. Riggins, Hong-Bin Fang, Robert Clarke

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis

    Analysis of MicroRNAs in Sputum to Improve Computed Tomography for Lung Cancer Diagnosis mā Jun Shen, Jipei Liao, Maria Guarnera, Hong‐Bin Fang, Ling Cai, Sanford A. Stass, Feng Jiang

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    A plasma miRNA signature for lung cancer early detection

    A plasma miRNA signature for lung cancer early detection mā Qixin Leng, Yanli Lin, Fangran Jiang, Cheng-Ju Lee, Min Zhan, Hong‐Bin Fang, Yue Wang, Feng Jiang

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis

    Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis mā Jian Su, Jeipi Liao, Lu Gao, Jun Shen, Maria Guarnera, Min Zhan, Hong‐Bin Fang, Sanford A. Stass, Feng Jiang

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2

    The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2 mā Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, Suneet Shukla, Hong-Bin Fang, Ling Cai, Zhe‐Sheng Chen, Suresh V. Ambudkar, Maria R. Baer

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

    Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers mā Lei Yu, Nevins W. Todd, Lingxiao Xing, Ying Xie, Howard Zhang, Zhenqiu Liu, Hong‐Bin Fang, Jian Zhang, Ruth L. Katz, Feng Jiang

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1<i>H</i>-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer

    Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1<i>H</i>-benzimidazole-1-yl)androsta-5,16-diene in prostat... mā Tadas S. Vasaitis, Aashvini Belosay, Adam Schayowitz, Aakanksha Khandelwal, Pankaj Chopra, Lalji K. Gediya, Zhiyong Guo, Hong‐Bin Fang, Vincent C.O. Njar, Angela Brodie

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer

    Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer mā Ying Xie, Nevins W. Todd, Zhenqiu Liu, Min Zhan, Hong-Bin Fang, Hong Peng, M M Al-Attar, Janaki Deepak, Sanford A. Stass, Feng Jiang

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

    Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias mā Ken Shiozawa, Takeo Nakanishi, Ming Tan, Hong-Bin Fang, Wen-chyi Wang, Martin J. Edelman, David P. Carlton, Ivana Gojo, Edward A. Sausville, Douglas D. Ross

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    PGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis

    PGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis mā Kavita Bhalla, Bor Jang Hwang, Ruby E. Dewi, Lihui Ou, William Twaddel, Hong‐Bin Fang, Scott B. Vafai, Francesca Vazquez, Pere Puigserver, László G. Boros, Geoffrey D. Girnun

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

    Plasma microRNAs as potential biomarkers for non-small-cell lung cancer mā Jun Shen, Nevins W. Todd, Howard Zhang, Lei Yu, Xing Lingxiao, Yuping Mei, Maria Guarnera, Jipei Liao, Amy Chou, Changwan Lu, Zhengran Jiang, Hong‐Bin Fang, Ruth L. Katz, Feng Jiang

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

    Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid... mā Ivana Gojo, Ming Tan, Hong‐Bin Fang, Mariola Sadowska, Rena G. Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rahul Srivastava, Igor Espinoza‐Delgado, Douglas D. Ross

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma

    The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma mā Cynthia M. Simbulan‐Rosenthal, Sivanesan Dakshanamurthy, Anirudh Gaur, You‐Shin Chen, Hong‐Bin Fang, Maryam Abdussamad, Hengbo Zhou, John L. Zapas, Valerie Calvert, Emanuel F. Petricoin, Michael B. Atkins, Stephen W. Byers, Dean S. Rosenthal

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules

    A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules mā Yanli Lin, Qixin Leng, Zhengran Jiang, Maria Guarnera, Yun Zhou, Xueqi Chen, Heping Wang, Wenxian Zhou, Ling Cai, Hong-Bin Fang, Jie Li, Hai‐Rong Jin, Linghui Wang, Shaoqiong Yi, Wei Lü, David L. Evers, Carol B. Fowle, Yun Su, Feng Jiang

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

    Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells mā Aaron P. Rapoport, Edward A. Stadtmauer, Nicole A. Aqui, Dan T. Vogl, Anne Chew, Hong‐Bin Fang, Stephen Janofsky, Kelly Yager, Elizabeth Veloso, Zhaohui Zheng, Todd Milliron, Sandra Westphal, Julio Cotte, Hong A. Huynh, Andréa Cannon, Saul Yanovich, Görgün Akpek, Ming Tan, Kristen Virts, Kathleen Ruehle, Carolynn Harris, Sunita Philip, Robert H. Vonderheide, Bruce L. Levine, Carl H. June

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: